GLOW with KPV added — the four-pathway recovery stack for researchers focused on gut inflammation, IBD models, or comprehensive gut + tissue healing. One vial, one injection.
KLOW is GLOW with KPV added. KPV (Lysine-Proline-Valine) is a tripeptide derived from alpha-melanocyte-stimulating hormone (α-MSH) with potent anti-inflammatory and gut-healing properties that complement and amplify the BPC-157 gut healing already present in the base formula.
KPV (Lys-Pro-Val) is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone — the anti-inflammatory signaling domain of α-MSH, without the pigmentation effects of the full molecule. It directly inhibits NF-κB, the master regulator of inflammatory gene expression. In gut models, KPV penetrates intestinal epithelial cells and reaches the nucleus — reducing inflammatory cytokine production at the source. Combined with BPC-157's gut-healing signaling, KLOW creates a two-vector anti-inflammatory and barrier repair approach that neither peptide achieves alone.
KPV + BPC-157 dual anti-inflammatory and barrier repair. KPV reduces NF-κB inflammatory signaling; BPC-157 stimulates gut epithelial repair and growth factor signaling. Together: the most comprehensive gut healing combination available.
KPV directly inhibits NF-κB nuclear translocation — the transcription factor controlling TNF-α, IL-6, IL-1β production. This is the primary mechanism behind KPV's documented effects in IBD and intestinal inflammation models.
GHK-Cu's collagen synthesis + BPC-157's tendon fibroblast activation + TB-500's cell migration work in complementary fashion to rebuild connective tissue from multiple angles simultaneously.
The BPC-157 + TB-500 recovery stack is intact inside KLOW — all the tendon, ligament, and tissue repair benefits, with KPV adding systemic anti-inflammatory support to reduce the inflammatory burden at injury sites.
BPC-157 activates VEGFR2; TB-500 drives cell migration-mediated angiogenesis. New blood vessel formation improves healing environment for gut lining and musculoskeletal tissue alike.
KPV (NF-κB inhibition) + GHK-Cu (collagen/gene reset) + BPC-157 (receptor signaling) + TB-500 (cell migration) — four distinct mechanisms, one reconstitution, one draw, one injection.
Same reconstitution and injection protocol as GLOW. Because KLOW is a four-analyte blend, the COA verifies each component separately — confirm identity and purity of all four before use.
| Parameter | Detail |
|---|---|
| Reconstitution | Add 2–5 mL bacteriostatic water gently to lyophilized powder |
| Frequency | Once daily or every other day |
| Route | Subcutaneous — abdomen, upper thigh |
| Cycle Length | 4 – 12 weeks depending on protocol goals |
| Storage (reconstituted) | Refrigerate; use within 30 days |
Choose GLOW for pure recovery, tissue repair, and skin regeneration. Choose KLOW when gut inflammation, IBD research, or combined gut + tissue healing is the primary focus. Both share the GHK-Cu + BPC-157 + TB-500 core.
KLOW is a pre-blended peptide combination sold for research purposes only. None of the components are FDA-approved drugs for the uses described. The information on this page is educational and does not constitute medical advice. Consult a qualified healthcare professional before any peptide protocol.
Pre-blended. Quad-analyte COA. Finnrick Analytics verified. Ships within 24 hours.
Get Started Today